is semaglutide oral or injection vs Injectable Semaglutide: Which Better for Weight Loss? The Semaglutide Pill vs. Injection:

Eli Lilly pricing in Mexico may shift as distribution expands

Oral GLP-1 Approaches Commercial Inflection by 2028 GLP-1 Weight Loss Drug Market Revenue Share, CAGR, and Primary Drivers by Route 2026 Subcutaneous injectable administration commands 81.7% GLP-1 market revenue share in 2026 as the weekly autoinjector format delivers clinical efficacy, dose consistency, and patient convenience superior to daily injectable alternatives

Other summaries note that cardiovascular complaints remain relatively uncommon

5.4.2 Single-cell epigenomic profiling Advanced single-cell technologies including scRNA-seq and ATAC-seq have revealed persistent chromatin accessibility changes in F1-F3 germ cells, providing unprecedented resolution of transgenerational epigenetic inheritance mechanisms (118, 119)